Utah Medical Products (NASDAQ:UTMD) Share Price Crosses Above Two Hundred Day Moving Average of $68.90

Utah Medical Products, Inc. (NASDAQ:UTMD) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $68.90 and traded as high as $69.30. Utah Medical Products shares last traded at $68.57, with a volume of 6,899 shares traded.

Utah Medical Products Price Performance

The company has a market cap of $238.62 million, a price-to-earnings ratio of 15.24 and a beta of 0.06. The stock has a 50 day simple moving average of $68.07 and a two-hundred day simple moving average of $68.85.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%. The firm had revenue of $10.40 million for the quarter.

Utah Medical Products Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 4th. Stockholders of record on Friday, September 20th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. Utah Medical Products’s dividend payout ratio is currently 26.67%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Northwest Financial Advisors acquired a new stake in shares of Utah Medical Products during the fourth quarter worth about $25,000. BNP Paribas Financial Markets lifted its position in Utah Medical Products by 101.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,766 shares of the medical instruments supplier’s stock worth $317,000 after acquiring an additional 1,899 shares during the period. Brandes Investment Partners LP grew its position in Utah Medical Products by 21.2% in the 4th quarter. Brandes Investment Partners LP now owns 32,825 shares of the medical instruments supplier’s stock valued at $2,765,000 after buying an additional 5,746 shares during the last quarter. Advisory Services Network LLC lifted its stake in shares of Utah Medical Products by 47.8% in the 4th quarter. Advisory Services Network LLC now owns 4,885 shares of the medical instruments supplier’s stock worth $411,000 after acquiring an additional 1,579 shares during the period. Finally, Isthmus Partners LLC increased its position in Utah Medical Products by 6.5% during the 4th quarter. Isthmus Partners LLC now owns 22,699 shares of the medical instruments supplier’s stock worth $1,912,000 after purchasing an additional 1,392 shares during the period. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.